Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
about
Biomarkers in community-acquired pneumonia: a state-of-the-art reviewThe prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical reviewNew role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failureThe association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohortSymptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised intervenEndothelial markers may link kidney function to cardiovascular events in type 2 diabetes.Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertensionShort-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF StudyProcalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis studyNovel biomarkers for cardiovascular risk prediction.Blood-based biomarkers of microvascular pathology in Alzheimer's disease.Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis.Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study.Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.Inflammatory response in mixed viral-bacterial community-acquired pneumoniaProhormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.Midregional pro-adrenomedullin plasma concentrations are blunted in severe preeclampsia.Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease.Adrenomedullin and endocrine control of immune cells during pregnancyRelation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT TrialMid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational studyMultiple biomarkers and atrial fibrillation in the general populationPre-analytic factors and initial biomarker levels in community-acquired pneumonia patients.Emerging biomarkers in heart failure and cardiac cachexiaPlasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke.Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction.Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity.Proadrenomedullin and copeptin in pediatric pneumonia: a prospective diagnostic accuracy studyBasal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection.Biomarker changes during acute heart failure treatment.Midregional Proadrenomedullin Improves Risk Stratification beyond Surgical Risk Scores in Patients Undergoing Transcatheter Aortic Valve Replacement.Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models.Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.Adrenomedullin and pregnancy: perspectives from animal models to humans.
P2860
Q27026995-9AE5F274-D96D-404E-AC97-7E3203E2F209Q27027653-353CE689-1155-4889-B8F1-5792804714B4Q28076596-4A3C260F-DAB4-48F0-95D1-0CD358DADC6AQ28742141-4B61AC05-CFC0-419F-A937-86D56A78416CQ30395217-FA1F0A91-8DE6-4751-A806-4A484F47D60FQ30434636-30F8BD35-357E-4B37-9E47-2C77BB489E38Q30481592-91C4DD47-EFEC-48C8-9E30-812459B660B2Q31131029-A6B0C9E5-685C-4F12-8AF0-A02AB9499819Q33290142-364BA913-ED33-4B11-89DF-8A3B13A4C110Q33526184-DC3B02FA-1EA4-475D-88DE-170F21C501A1Q33530066-27862542-C40E-4E0E-9184-45DDF7A281EAQ33615459-27E1B6B7-8E25-475B-BF79-288545FB768FQ33625663-CADC5E35-1CB7-4E02-9305-7C69ACC40222Q33637592-EB05B80A-0C74-4BF6-9D9B-FC634C1EF351Q33750991-034E9D9C-ADA8-49DC-9A64-1ACB8309C337Q33869378-EC9B275E-EF4A-4DDA-A15D-32A8C5141F0DQ33888706-E1057916-AA80-4A9A-A096-AF4E64A88D83Q33987876-C21E2E6D-4BAA-44BC-AE19-8E96A2F23405Q34026975-C8BEF8BF-633C-46E0-8871-8CF1BFD38E51Q34084503-EB23D5D6-E67E-409A-8BEB-AB8F3BED986EQ34241396-87CE8CF4-AE78-4DCC-B0F9-C872060E16FDQ34339823-795A940E-3D2E-4597-942C-942D3A718691Q34381858-A1B755D5-45B1-4C6B-A65C-15337947649DQ34480748-6707E30D-4393-4469-8218-86D918420D3DQ34525092-06D87FEC-B04F-4C7E-9D0E-DB66765DA8FEQ34558232-18F0B43D-7879-474D-B5F7-5F78A36644D3Q34836097-51B2048C-2AF7-4AD3-BF1F-8720F63ADF9CQ34873180-CC0AD1CF-B13A-4FA9-9BE3-98E9A77DB541Q34960396-1D742FBD-6EE6-41AF-9C98-DE9BB3032ADEQ34999555-4F0AE068-5CEB-495F-B025-BA8F3ED980F5Q35003806-00454044-879D-451E-A98E-5F29D315FBD3Q35622257-047BF98F-AAE3-4425-B149-74EBC111FB13Q35718443-B70923B8-1605-4C37-B494-30C96DA7D7B7Q35749409-648A4A81-DD47-44CC-B5C0-23D3454A9CF0Q35850091-D8948126-2D58-4CAE-AE4E-9771C15B50EEQ35854988-2A727F88-995B-4EDD-A922-36F36EC76142Q35858729-A0E45B39-FF9F-4522-95AA-E1B5C13310F4Q35952350-26158196-ACD6-4BD5-BD6C-0BAD88FB64A7Q36031663-CD4F119B-C50B-43CD-B72A-F7EB0D3FC966Q36049471-47430B25-F85E-4669-9976-FF9C4DE0B1BC
P2860
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@en
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@nl
type
label
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@en
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@nl
prefLabel
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@en
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@nl
P2093
P1433
P1476
Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay.
@en
P2093
Andreas Bergmann
Christine Alonso
Joachim Struck
Nils G Morgenthaler
P304
P356
10.1373/CLINCHEM.2005.051110
P407
P577
2005-08-11T00:00:00Z